6:09 PM
 | 
Apr 28, 2008
 |  BC Extra  |  Financial News

Medarex down on ipilimumab news

Medarex (NASDAQ:MEDX) fell $0.66 to $7.35 on Monday after it and partner Bristol-Myers (NYSE:BMY) said late Friday...

Read the full 71 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >